Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 7-Day Trial for You or Your Team.

Learn More →

Mutations of optineurin in amyotrophic lateral sclerosis

Mutations of optineurin in amyotrophic lateral sclerosis About 10% of cases of the motor neuron disease amyotrophic lateral sclerosis (ALS) are familial, but the small number of mutations so far identified account for only around 20–30% of the those cases. A new study of individuals from ALS-carrying families has now identified three different and previously unknown mutations of OPTN, the gene encoding optineurin. OPTN was earlier reported to be the causative gene of rare familial glaucoma. Optineurin's ability to inhibit activation of the regulatory protein NF-κB is lost in the mutant forms, suggesting that NF-κB inhibitors might be useful in ALS treatment. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Nature Springer Journals

Loading next page...
 
/lp/springer-journals/mutations-of-optineurin-in-amyotrophic-lateral-sclerosis-07w0Jnzbme

References (25)

Publisher
Springer Journals
Copyright
Copyright © 2010 by Macmillan Publishers Limited. All rights reserved
Subject
Science, Humanities and Social Sciences, multidisciplinary; Science, Humanities and Social Sciences, multidisciplinary; Science, multidisciplinary
ISSN
0028-0836
eISSN
1476-4687
DOI
10.1038/nature08971
Publisher site
See Article on Publisher Site

Abstract

About 10% of cases of the motor neuron disease amyotrophic lateral sclerosis (ALS) are familial, but the small number of mutations so far identified account for only around 20–30% of the those cases. A new study of individuals from ALS-carrying families has now identified three different and previously unknown mutations of OPTN, the gene encoding optineurin. OPTN was earlier reported to be the causative gene of rare familial glaucoma. Optineurin's ability to inhibit activation of the regulatory protein NF-κB is lost in the mutant forms, suggesting that NF-κB inhibitors might be useful in ALS treatment.

Journal

NatureSpringer Journals

Published: Apr 28, 2010

There are no references for this article.